Predictors of survival among HIV-positive children on ART in Swaziland

References

• Bolton-Moore, C., Mubiana-Mbewe, M., Cantrell, R. A., Chintu, N., Stringer, E. M., Chi, B. H., … Stringer, J. S. A. (2007). Clinical outcomes and CD4 cell cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Journal of the American Medical Association, 298(16), 1888–1899. https://doi.org/10.1001/jama.298.16.1888
   PubMed Web of Science ®Google Scholar
• Callens, F. S. S., Shabani, N., Lusiama, J., Lelo, P., Kitetele, F., Colebunders, R., … Behets, F. (2009). Mortality and associated factors after initiation of pediatric antiretroviral treatment in the democratic republic of Congo. The Pediatric Infectious Disease Journal, 28(1), 35–40. https://doi.org/10.1097/INF.0b013e318184eeb9
   PubMed Web of Science ®Google Scholar
• Collett, D. (2003). Modelling survival data in medical research (2nd ed.). Florida, USA: CRC Press LLC.
   Google Scholar
• Cotton, F., Violari, A., Otwombe, K., Panchia, R., Dobbels, E., Rabie, H., … Babiker, A. G. (2013). Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet, 382(9904), 1555–1563. https://doi.org/10.1016/S0140-6736(13)61409-9
   PubMed Web of Science ®Google Scholar
• Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R. Jr., & Hopewell, P. C. (1992). An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms. The New England Journal of Medicine, 326(4), 231–235. https://doi.org/10.1056/NEJM199201233260404
   PubMed Web of Science ®Google Scholar
• Ferris, M., Burau, K., Constantin, A. M., Mihale, S., Murray, N., Preda, A., … Kline, M. W. (2007). Influence of institutionalization on time to HIV disease progression in a cohort of Romanian children and teens. Pediatrics, 120(6), 1476–1480. https://doi.org/10.1542/peds.2006-1503
   Web of Science ®Google Scholar
• Green, H., Gibb, D. M., Walker, A. S., Pillay, D., Butler, K., & Candeias, F. (2007). Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS (London, England), 21(8), 947–955. https://doi.org/10.1097/QAD.0b013e3280e087e7
   PubMed Web of Science ®Google Scholar
• Jaffar, S. S., Amuron, B., Foster, S., Birungi, J., Levin, J., Namara, G., … Grosskurth, H. (2009). Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: A cluster-randomized equivalence trial. Lancet, 374(9707), 2080–2089. https://doi.org/10.1016/S0140-6736(09)61674-3
   PubMed Web of Science ®Google Scholar
• Janssens, B., Raleigh, B., Soeung, S., Akao, K., Te, V., Gupta, J., … Nerrienet, E. (2007). Effectiveness of highly active antiretroviral therapy in HIV-positive children: Evaluation at 12 months in a routine program in Cambodia. Pediatrics, 120(5), 1134–1140. doi: 10.1542/peds.2006-3503
   Web of Science ®Google Scholar
• Kipp, W. W., Konde-Lule, J., Saunders, L. D., Alibhai, A., Houston, S., Rubaale, T., … Kiweewa, F. (2010). Results of a community- based antiretroviral treatment program for HIV-1 infection in western Uganda. Current HIV Research, 8(2), 179–185. https://doi.org/10.2174/157016210790442722
   PubMed Web of Science ®Google Scholar
• Klein, J. P., & Moeschberger, M. L. (1997). Survival Analysis Technique for Censored and Truncated data (1st ed.). New York, USA: Spinger-Verlag New York, Inc.
   Google Scholar
• Lennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V., Berger, D. S., … Sklar, P. (2009). Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: A multicentre, double-blind randomized controlled trial. Lancet, 374(9692), 796–806. https://doi.org/10.1016/S0140-6736(09)60918-1
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Hislop, M., Dowdy, D. W., Lo, M., Omer, B. S., Regensberg, L., … Maartens, G. (2006). Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(1), 78–84. https://doi.org/10.1097/01.qai.0000225015.43266.46
   PubMed Web of Science ®Google Scholar
• Nacro, B., Zoure, E., Hien, H., Tamboura, H., Rouet, F., Ouiminga, A., … Msellati, P. (2011). Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial. Bulletin of the World Health Organization, 89(6), 451–458. https://doi.org/10.2471/BLT.10.081646
   PubMed Web of Science ®Google Scholar
• Newell, M. L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., & Dabis, F. (2004). Mortality of infected and uninfected infants born to HIV infected mother in Africa: A pooled analysis. Lancet, 364(9441), 1236–1243. https://doi.org/10.1016/S0140-6736(04)17140-7
   PubMed Web of Science ®Google Scholar
• Niekerk, N. K. M., Knies, M. M., Howard, J., Rabie, H., Zeier, M., Van Rensburg, A., & Frans, N. (2006). The first 5 years of the family clinic for HIV at Tygerberg hospital: Family demographics, survival of children and early impact of antiretroviral therapy. Journal of Tropical Pediatrics, 52(1), 3–11. https://doi.org/10.1093/tropej/fmi047
   PubMed Web of Science ®Google Scholar
• Pagano, M., & Gauvreau, K. (2000). Principles of Biostatistics (2nd ed.). Belmont: Brooks/Cole.
   Google Scholar
• Patel, K., Ming, X., Williams, P. L., Robertson, K. R., Oleske, J. M., & Seage, G. R., III. (2009). Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS (London, England), 23(14), 1893–1901. https://doi.org/10.1097/QAD.0b013e32832dc041
   PubMed Web of Science ®Google Scholar
• Persaud, D., Gay, H., & Ziemniak, C. F. (2013). Functional HIV cure after very early ART of an infected infant. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA, USA: March 3-6, Abstract 48LB.
   Google Scholar
• Reddi, A., Leeper, C., Grobler, A. C., Geddes, R., France, H. K., & Dorse, G. L. (2007). Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics, 7(13), 1–13.
   PubMedGoogle Scholar
• Resino S, Bellón JM, Gurbindo D, Ramos JT, León JA, Muñoz-Fernández MA. (2002). Responses to antiretroviral treatments in vertically HIV-1-infected children. Med Clin (Barc) 2, 119(19):725–729. doi: 10.1016/S0025-7753(02)73557-4
   PubMed Web of Science ®Google Scholar
• Rovny, J. (2014, May 8). Multicollinearity and Heteroscedasticity. Retrieved from http://www.rovny.org/Site/Applied_Methods_files/10.Multicollinearity&Het.pdf
   Google Scholar
• Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., & the ANRS VISCONTI Study Group. (2013). Post-treatment HIV-1 controllers with long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathogens, 9(3), 1–12. doi: 10.1371/journal.ppat.1003211
   Web of Science ®Google Scholar
• Sauvageot, D., Schaefer, M., Olson, D., Pujades-Rodriguez, M., & O’Brien, D. P. (2010). Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age. Pediatrics, 125(5), 1039–1047. https://doi.org/10.1542/peds.2009-1062
   PubMed Web of Science ®Google Scholar
• Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., & Klein, R. S. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England Journal of Medicine, 320(9), 545–550. https://doi.org/10.1056/NEJM198903023200901
   PubMed Web of Science ®Google Scholar
• Sterne, A. J., May, M., Costagliola, D., De Wolf, F., Phillips, A. N., & Harris, R. (2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies. Lancet, 373(9672), 1352–1363. https://doi.org/10.1016/S0140-6736(09)60612-7
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2010). Swaziland HIV estimates and Projections report. Mbabane: Joint United Nations Programme on HIV/AIDS (UNAIDS).
   Google Scholar
• UNAIDS. (2012). UNAIDS Report on the Global AIDS Epidemic 2012. Geneva: WHO Library Cataloguing in Publication Data.
   Google Scholar
• UNAIDS. (2013). UNAIDS Report on the Global AIDS Epidemic 2013. Geneva: WHO Library Cataloguing in Publication Data.
   Google Scholar
• Wamalwa, C. D., Obimbo, E., Farquhar, C., Richardson, A. B., Mbori-Ngacha, A., & Inwani, I. (2010). Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: A prospective cohort. BMC Pediatrics, 10(13), 2–8.
   PubMedGoogle Scholar
• WHO. (2010). Antiretroviral Therapy for HIV infection in infants and children: Towards universal access. Geneva: WHO Press.
   Google Scholar
• WHO. (2013a, September 14). Treatment of children living with HIV. Geneva, Switzerland: World Health Organization. Retrieved from http://www.who.int/hiv/topics/paediatric/en/index.html
   Google Scholar
• WHO. (2013b). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO Press.
   Google Scholar
• WHO. (2015). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO Press.
   Google Scholar
• Williams R. (2014, June 5). Multicollinearity. University of Notre Dame, Indiana, USA. Retrieved from https://www3.nd.edu/~rwilliam/stats2/l11.pdf
   Google Scholar